greeksoup/ stock research
Stock research / United States / BMY / FY2007

Bristol-Myers Squibb (BMY) FY2007 results: revenue $15.6 billion

Bristol-Myers Squibb Co. (BMY) reported revenue of $15.6 billion for fiscal 2007, the year ended 31 December 2007. Net income was $2.2 billion, and diluted earnings per share $1.09. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2010.

Revenue
$15.6 billion
FY2007FY2007
Operating margin
16.2%
FY2007FY2007
Net income
$2.2 billion
FY2007FY2007
Diluted EPS
$1.09
FY2007FY2007

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2007Last 8 years
Revenue15,617
Cost of revenue4,919
Gross profit10,698
Gross margin68.5%
Research and development3,160
Selling, general and administrative3,941
Operating income2,523
Operating margin16.2%
Pre-tax income2,523
Income tax471
Effective tax rate18.7%
Net income2,165
Net margin13.9%
Diluted EPS$1.09
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2007Last 8 years
Operating cash flow3,153
Capital expenditure843
Free cash flow2,310
Free cash flow margin14.8%
Cash from investing-202
Cash from financing-3,213
Share-based compensation133
Dividends paid2,213
Dividend per share$1.15

Balance sheet

$ millionFY2007Last 8 years
Intangible assets1,330
Cash and equivalents1,801

10-K for the year ended 31 December 2007, filed 19 February 2010: the filing.